Ruthenium arene complex induces cell cycle arrest and apoptosis through activation of P53-mediated signaling pathways

Last Updated July 2023 Refereed Papers/Articles CA Keet, SH Sicherer, S Bunyavanich, C Visness, PC Fulkerson, A Togias, W Davidson, S Perry, S Hamrah, A Calatroni, K Robinson, L Dunaway, CM Davis, S Anvari, SM Leong‐Kee, GK Hershey, E DeFranco, A Devonshire, H Kim, C Joseph, B Davidson, NK Strong, AJ Tsuang, M Groetch, J Wang, J Dantzer, K Mudd, A AIna, W Shreffler, Q Yuan, V Simmons, DYM Leung, J Hui‐Beckman, JA Ramos, RS Chinthrajah, V Winn, S Sindher, SM Jones, NA Manning, AM Scurlock, EH Kim, A Stuebe, JE Gern, AM Singh, J Krupp, RA Wood. The SunBEAm birth cohort: Protocol design. J Allergy Clin Immunol Global. 2023; doi: 10.1016/j.jacig.2023.100124 M Greenhawt, SB Sindher, J Wang, M O’Sulllivan, G du Toit, EH Kim, D Albright, S Anvari, N Arends, PD Arkwright, P Begin, K Blumchen, T Bourrier, T Brown‐Whitehorn, H Cassell, ES Chan, CE Ciaccio, A Deschildre, A Divaret‐Chauve, SL Dorris, MJ Dorsey, T Eiwegger, M Erlewyn‐Lajeunesse, DM Fleischer, LS Ford, M Garcia‐Lloret, L Giovannini‐Chami, JO Hourihane, N Jay, SM Jones, L Kerns. KM Kloepfer, S Leonard, G Lezmi, JA Lieberman, J Lomas, M Makhija, C Parrish, J Peake, KP Perrett, D Petroni, W Pfutzner JA Pongracic, P Quinn, RG Robison, G Sanders, L Schneider, HP Sharma, J Trujillo, PJ Turner, K Tuttle, JEM Upton, P Varshney, BP Vickery, C Vogelberg, B Wainstein, RA Wood, KJ Bee, DE Campbell, TD Green, R Rouissi, A Peillon, HT Bahnson, T Bois, HA Sampson, AW Burks. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Eng J Med. 2023; doi: 10.1056/NEJMoa2212895 EH Kim, CA Keet, YV Virkud, S Chin, P Ye, A Penumarti, J Smeekens, R Guo, X Yue, Q Li, MR Kosorok, MD Kulis, AW Burks. Open‐label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut‐allergic children. J Allergy Clin Immunol. 2023; doi: 10.1016/j.jaci.2023.01.036 ACY Foo, JB Nesbit, SAY Gipson, EF DeRose, H Cheng, BK Hurlburt, MD Kulis, EH Kim, S Dreskin, S Mustafa, SJ Maleki, GA Mueller. Structure and IgE Cross‐Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin‐Buried Peptides. J Agric Food Chem. 2023; doi: 10.1021/acs.jafc.2c07061 M Groetch, K Mudd, M Woch, A Schiable, BE Gray, S Jones, EH Kim, BJ Lanser, J Poyser, N Rogers, DC Babineau, A Rudman‐Spergel, W Shreffler, S Sicherer, J Spergel, BP Vickery, R Wood, JA Bird, RS Chinthrajah. Retail food equivalents for post‐OIT dosing in the OUtMATCH clinical trial. J Allergy Clin Immunol Pract. 2022; doi: 10.1016/j.jaip.2022.10.022 EG Liu, B Zhang, V Martin, J Anthonypillai, M Kraft, A Grishin, G Grishina, RS Chinthrajah, T Sindher, M Manohar, Z Quake, K Nadeau, AW Burks, EH Kim, MD Kulis, AK Henning, SM Jones, DYM Leung, SH Sicherer, Q Yuan, W Shreffler, HA Sampson, V Chabanova, SC Eisenbarth. Food‐specific Immunoglobulin A Does Not Correlate with Natural Tolerance to Peanut or Egg Allergens. Sci Transl Med. 2022; doi: 10.1126/scitranslmed.abq0599 EC Steinbach, JM Smeekens, S Roy, T Toyonaga, C Cornaby, L Perini, A Berglind, MD Kulis, EH Kim, MT Ferris, TS Furey, AW Burks, SZ Sheikh. Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin‐like 4 identified in orally‐susceptible peanut allergy model. Clin Exp Allergy. 2022; doi: 10.1111/cea.14248 JA Dantzer, EH Kim, RS Chinthrajah, RA Wood. Treatment for Food Allergy: Current Status and Unmet Needs. J Allergy Clin Immunol. 2022; doi: 10.1016/j.jaci.2022.08.008 J Smeekens, C Baloh, N Lim, D Larson, T Qin, L Wheatley, EH Kim, SM Jones, AW Burks, MD Kulis. Peanut‐ Specific IgG4 and IgA in Saliva are Modulated by Peanut OIT. J Allergy Clin Immunol Pract. 2022; doi: 10.1016/j.jaip.2022.07.030 P Purswani, EH Kim. Food allergy: History, definitions, and treatment approaches. J Food Allergy. 2022; doi: 10.2500/jfa.2022.4.220007 RA Wood, RS Chinthrajah, AKR Spergel, DC Babineau, SH Sicherer, EH Kim, WG Shreffler, SM Jones, DYM Leung, BP Vickery. JA Bird, JM Spergel, MD Kulis, A Iqbal, D Kaufman, DT Umetsu, M Ligueros‐ Saylan, A Uddin, RB Fogel, S Lussier, K Mudd, J Poyser, M MacPhee, M Veri, W Davidson, S Hamrah, A Long, A Togias. Protocol Design and Synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multi‐Allergen OIT in Food Allergic Children and Adults (OUtMATCH). J Allergy Clin Immunol Global. 2022; doi: 10.1016/j.jacig.2022.05.006 MD Kulis, JM Smeekens, C Burk, X Yue, R Guo, KA Orgel, P Ye, L Herlihy, D Hamilton, Q Li, W Shreffler, BP Vickery, AW Burks, EH Kim. Kinetics of basophil hyporesponsiveness during short‐course peanut OIT. J Allergy Clin Immunol. 2022; doi: 10.1016/j.jaci.2022.05.020 AW Winslow, A Gilmore, EH Kim. Peanut anaphylaxis in 2022 ‐ Decoupling epinephrine usage from emergency department evaluation. Annals Allergy Clin Immunol. 2022; doi: 10.1016/j.anai.2022.06.007 RS Chinthrajah, SM Jones, EH Kim, SH Sicherer, W Shreffler, BJ Lanser, N Atri, DC Babineau, DC Adelman, A Iqbal, SL Limb, AKR Spergel, A Togias, RA Wood. Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. J Allergy Clin Immunol. 2022; doi:10.1016/j.jaci.2021.12.789 SM Jones, EH Kim, KC Nadeau, A Nowak‐Wegrzyn, RA Wood, HA Sampson, AM Scurlock, S Chinthrajah, J Wang, RD Pesek, SB Sindher, M Kulis, J Johnson, K Spain, DC Babineau, H Chin, J Laurienzo‐Panza, R Yan, D Larson, T Qin, E Wambre, J Calise, D Whitehouse, ML Sever, S Sanda, M Plaut, LM Wheatley, AW Burks. Efficacy and Safety of Oral Immunotherapy in a Randomized, Placebo‐Controlled Study of 1‐3‐ Year Old Children with Peanut Allergy: Findings from the Immune Tolerance Network IMPACT Trial. Lancet. 2022; doi: 10.1016/S0140‐6736(21)02390‐4 N Liao, R Scherzer, EH Kim. Effective Methods of Clinical Education. Annals Allergy Clin Immunol. 2022; doi: 10.1016/j.anai.2021.11.021 MC Berin, C Agashe, AW Burks, D Chiang, WF Davidson, P Dawson, A Grishin, AK Henning, SM Jones, EH Kim, DYM Leung, M Masilamani, AM Scurlock, SH Sicherer, RA Wood, HA Sampson. Allergen‐specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts. J Allergy Clin Immunol. 2022; doi: 10.1016/j.jaci.2021.09.029 C Nilsson, A Gladbach, M Krawiec, K Blumchen, EH Kim, A Deschildre, V Sharma, AH Assa’ad, JE Trujillo, K Brown, SA Leonard, A Vereda, A Abbas, T Pham, A Muraro, MD Ibanez. Immunologic Outcomes of daily oral Immunotherapy for Peanut Allergy in Children and Adolescents: Longitudinal Analyses up to 6 Years. Allergologie. 2022; 45(8):594‐595. JA Pongracic, R Gagnon, G Sussman, D Siri, RC Oriel, T Brown‐Whitehorn, TD Green, DE Campbell, S Anvari, WE Berger, JA Bird, ES Chan, A Cheema, S Chinthrajah, H Chong, PJ Dowling, SM Fineman, DM Fleischer, E Gonzalez‐Reyes, EH Kim, BJ Lanser, A MacGinnitie, H Mehta, D Petroni, N Rupp, LC Schneider, AM Scurlock, LD Sher, WG Shreffler, SB Sindher, A Stillerman, R Wood, WH Yang, T Bois, HA Sampson, P Begin. Safety of Epicutaneous Immunotherapy in Peanut‐Allergic Children: REALISE Randomized Clinical Trial Results. J Allergy Clin Immunol Pract. 2022; doi: 10.1016/j.jaip.2021.11.017 A Hung, JM Gonzalez, J Yang, S Hass, EH Kim, FR Johnson. Heterogeneity in Parent Preferences for Peanut Desensitization Therapy. J Allergy Clin Immunol Pract. 2021; doi: 10.1016/j.jaip.2021.04.058 EGA Iglesia, EH Kim. Shorter "time to peanut introduction" can prevent peanut allergy and avert false Ara h 2 screening results in infants. J Allergy Clin Immunol. 2021; doi: 10.1016/j.jaci.2021.03.039 HG Smith, EH Kim. Increasing diversity in peanut oral immunotherapy research and accessibility. J Allergy Clin Immunol Pract. 2021; doi: 10.1016/j.jaip.2021.02.010 BP Vickery, A Vereda, C Nilsson, G Du Toit, WG Shreffler, AW Burks, SM Jones, M Fernandez‐Rivas, K Blumchen, JOB Hourihane, K Beyer, A Anagnostou, AH Assa’ad, M Ben‐Shoshan, JA Bird, TF Carr, WW Carr, TB Casale, HJ Chong, CE Ciaccio, MJ Dorsey, SM Fineman, SB Fritz, AN Greiner, LS Greos, FC Hampel, MD Ibanez, DK Jeong, DT Johnston, R Kachru, EH Kim, BJ Lanser, SA Leonard, MC Maier, LE Mansfield, A Muraro, JA Ohayon, JNGO Elberink, DH Petroni, JA Pongracic, JM Portnoy, R Rachid, NT Rupp, GM Sanders, HP Sharma, V Sharma, ER Sher, L Sher, SB Sindher, D Siri, JM Spergel, AB Sprikkelman, GL Sussman, M Tsoumani, P Varshney, G Vitalpur, J Wang, WH Yang, JM Zubeldia, A Smith, R Ryan, DC Adelman. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2‐Year Open‐Label Follow‐On Study. J Allergy Clin Immunol Pract. 2021; doi: 10.1016/j.jaip.2020.12.029 J MacDougall, AW Burks, EH Kim. Current Insights into Immunotherapy Approaches for Food Allergy. Immunotargets Ther. 2021; doi: 10.2147/ITT.S266257 SM Barshow, MD Kulis, AW Burks, EH Kim. Mechanisms of Oral Immunotherapy. Clin Exp Allergy. 2021; doi: 10.1111/cea.13824 A Penumarti, N Szczepanski, J Kesselring, E Gabel, R Sheth, J Berglund, EH Kim, AW Burks, MD Kulis. Irradiated Tree Nut Flours for Use in Oral Immunotherapy. J Allergy Clin Immunol Pract. 2021; doi: 10.1016/j.jaip.2020.11.008 L Herlihy, EH Kim, AW Burks, H Barber, Q Cook, L Yang, DK Hamilton, BP Vickery. Five‐year Follow‐up of Early Intervention Peanut Oral Immunotherapy. J Allergy Clin Immunol Pract. 2021; doi: 10.1016/j.jaip.2020.07.009 AM Scurlock, AW Burks, SH Sicherer, DYM Leung, EH Kim, AK Henning, P Dawson, RW Lindblad, MC Berin, CB Cho, WF Davidson, M Plaut, HA Sampson, RA Wood, SM Jones. Epicutaneous Immunotherapy for Treatment of Peanut Allergy: Follow‐up from the Consortium for Food Allergy Research. J Allergy Clin Immunol. 2021; doi: 10.1016/j.jaci.2020.11.027 EH Kim, TT Perry, RA Wood, DYM Leung, MC Berin, AW Burks, CB Cho, SM Jones, A Scurlock, SH Sicherer, AK Henning, P Dawson, RW Lindblad, M Plaut, HA Sampson. Induction of Sustained Unresponsiveness After Egg Oral Immunotherapy Compared to Baked Egg Therapy in Egg‐allergic Children. J Allergy Clin Immunol. 2020; doi: 10.1016/j.jaci.2020.05.040 SA Schworer, EH Kim. Sublingual Immunotherapy for Food Allergy and its Future Directions. Immunotherapy. 2020; doi: 10.2217/imt‐2020‐0123 Q Cook, L Yang, A Hamad, H Barber, L Herlihy, AW Burks, EH Kim. Dosing, Safety, and Quality of Life After Peanut Immunotherapy Trials – a Long‐term Follow Up Study. J Allergy Clin Immunol Pract. 2020; doi: 10.1016/j.jaip.2020.04.021 DM Fleischer, WG Shreffler, DE Campbell, TD Green, S Anvari, A Assa’ad, P Bégin, K Beyer, JA Bird, T Brown‐ Whitehorn, A Byrne, ES Chan, A Cheema, S Chinthrajah, H Chong, CM Davis, LS Ford, R Gagnon, M Greenhawt, JO Hourihane, SM Jones, EH Kim, L Lange, BJ Lanser, S Leonard, V Mahler, A Maronna, A Nowak‐Wegrzyn, RC Oriel, M O’Sullivan, D Petroni, JA Pongracic, SL Prescott, LC Schneider, P Smith, D Staab, G Sussman, R Wood, WH Yang, R Lambert, A Peillon, T Bois, HA Sampson. Long‐Term, Open‐ Label Extension Study of the Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Children: PEOPLE 3‐Year Results. J Allergy Clin Immunol. 2020; doi: 10.1016/j.jaci.2020.06.028 DM Fleischer, JM Spergel, EH Kim, DE Campbell, TD Green, KJ Bee, RLambert, T Ocheltree, HA. Sampson. Evaluation of Daily Patch Application Duration for Epicutaneous Immunotherapy for Peanut Allergy. Allergy Asthma Proc. 2020; doi: 10.2500/aap.2020.41.200045 M Greenhawt, EH Kim, DE Campbell, TD Green, R Lambert, DM Fleischer. Improvements in Eliciting Dose Across Baseline Sensitivities Following 12 Months of Epicutaneous Immunotherapy (EPIT) in Peanut‐Allergic Children Aged 4 to 11 Years. J Allergy Clin Immunol Pract, 2020; doi: 10.1016/j.anai.2020.01.030 M Greenhawt, M Shaker, T Winders, D Buckstein, R Davis, DM Fleischer, EH Kim, E Chan, D Stukus, D Matlock. Development and Acceptability of a Shared Decision‐Making Tool for Commercial Peanut Allergy Therapies. Ann Allergy Clin Immunol. 2020; doi: 10.1016/j.anai.2020.01.030 EGA Iglesia, EH Kim. Low‐risk infants may still benefit from allergenic food consumption. J Allergy Clin Immunol. 2020; doi: 10.1016/j.jaci.2020.01.016. EH Kim, AW Burks. Food Allergy Immunotherapy: OIT and EPIT. Allergy. 2020; doi: 10.1111/all.14220 EH Kim, C Patel, AW Burks. Immunotherapy Approaches for Peanut Allergy. Expert Review of Clinical Immunology. 2020; doi: 10.1080/1744666X.2019.1708192 EH Kim, SM Jones, AW Burks, RA Wood, SH Sicherer, DYM Leung, AK Henning, RW Lindblad, P Dawson, C Keet, AM Scurlock, M Plaut, HA Sampson. A 5‐year Summary of Real‐life Dietary Egg Consumption after Completion of a 4‐year Egg OIT Protocol. J Allergy Clin Immunol. 2020; doi: 10.1016/j.jaci.2019.11.045 PWW Gamage, M Chaudhari, CS McMahan, EH Kim, MR Kosorok. An extended proportional hazards model for interval‐censored data subject to instantaneous failures. Lifetime Data Anal. 2020; doi: 10.1007/s10985‐ 019‐09467‐z OL Francis, KY Wang, EH Kim, TP Moran. Common Food Allergens and Cross‐Reactivity. J Food Allergy. 2020; doi: 10.2500/jfa.2020.2.200020 EH Kim, L Yang, P Ye, R Guo, Q Li, MD Kulis, AW Burks. Long‐Term Sublingual Immunotherapy for Peanut Allergy in Children: Clinical and Immunologic Evidence of Desensitization. J Allergy Clin Immunol. 2019; doi: 10.1016/j.jaci.2019.07.030. BC Remington, T Krone, EH Kim, JA Bird, TD Green, G Lack, DM Fleischer, SJ Koppelman. Estimated Risk Reduction to Packaged Food Reactions by Epicutaneous Immunotherapy (EPIT) for Peanut Allergy. Ann Allergy Asthma Immunol. 2019; doi: 10.1016/j.anai.2019.08.007. DM Fleischer, M Greenhawt, G Sussman, P Bégin, A Nowak‐Wegrzyn, D Petroni, K Beyer, T Brown‐ Whitehorn, J Hebert, JO Hourihane, DE Campbell, S Leonard, RS Chinthrajah, JA Pongracic, SM Jones, L Lange, H Chong, TD Green, R Wood, A Cheema, SL Prescott, P Smith, W Yang, ES Chan, A Byrne, A Assa'ad, JA Bird, EH Kim, L Schneider, CM Davis, BJ Lanser, R Lambert, W Shreffler. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019; doi: 10.1001/jama.2019.1113 Q Cook, E Kim. Update on Peanut Allergy: Prevention and Immunotherapy. Allergy Asthma Proc. 2019; doi: 10.2500/aap.2019.40.4190 M Kulis, X Yue, R Guo, H Zhang, K Orgel, P Ye, Q Li, Y Liu, E Kim, A Burks, B Vickery. High and Low Dose Oral Immunotherapy Similarly Suppress Pro‐Allergic Cytokines and Basophil Activation in Young Children. Clin Exp Allergy. 2019; doi: 10.1111/cea.13256 BP Vickery, A Vereda, TB Casale, K Beyer, G du Toit, JO Hourihane, SM Jones, WG Shreffler, A Marcantonio, R Zawadzki, L Sher, WW Carr, S Fineman, L Greos, R Rachid, MD Ibáñez, S Tilles, AH Assa’ad, C Nilsson, N Rupp, MJ Welch, G Sussman, S Chinthrajah, K Blumchen, E Sher, JM Spergel, FE Leickly, S Zielen, J Wang, GM Sanders, RA Wood, A Cheema, C Bindslev‐Jensen, S Leonard, R Kachru, DT Johnston, FC Hampel, EH Kim, A Anagnostou, JA Pongracic, M Ben‐ Shoshan, HP Sharma, A Stillerman, HH Windom, WH Yang, A Muraro, JM Zubeldia, V Sharma, MJ Dorsey, HJ Chong, J Ohayon, JA Bird, TF Carr, D Siri, M Fernández‐Rivas, DK Jeong, DM Fleischer, JA Lieberman, AEJ Dubois, M Tsoumani, CE Ciaccio, JM Portnoy, LE Mansfield, SB Fritz, BJ Lanser, J Matz, JNGO Elberink, P Varshney, SG Dilly, DC Adelman, AW Burks. AR101 Oral Immunotherapy for Peanut Allergy. N Eng J Med. 2018; doi: 10.1056/NEJMoa1812856 M Chaudhari, EH Kim, PW Gamage, CS McMahan, MR Kosorok. Study Design with Staggered Sampling Times for Evaluating Sustained Unresponsiveness to Peanut Sublingual Immunotherapy. Stat Med. 2018; doi: 10.1002/sim.7857 WG Shreffler, JL Baumert, BC Remington, SJ Koppelman, C Dinakar, DM Fleischer, EH Kim, SA Tilles, JM Spergel. The Importance of Reducing risk in Peanut Allergy: Current and Future Therapies. Ann Allergy Asthma Immunol. 2018; 120:124‐7. doi: 10.1016/j.anai.2017.10.038 JA Bird, J Spergel, S Jones, R Rachid, A Assa’ad, J Wang, SA Leonard, S Laubach, EH Kim, BP Vickery, BP Davis, J Heimall, A Cianferoni, AJ MacGinnitie, E Crestani, W Burks. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double‐blind, Placebo‐ controlled Phase‐2 Clinical Trial. J Allergy Clin Immunol In Pract. 2018; doi: 10.1016/j.jaip.2017.09.016 A Hamad, OI Iweala, C Henderson, S Madan, GA Stouffer 3rd, SP Commins, EH Kim. Recurrent Anaphylaxis During Cardiac Catheterization Due to Ethylene Oxide. J Allergy Clin Immunol Pract. 2018; doi: 10.1016/j.jaip.2018.04.017 HX Chen, R Blasiak, E Kim, R Padilla, DA Culton. Triggers of Oral Lichen Planus Flares and the Potential Role of Trigger Avoidance in Disease Management. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; doi: 10.1016/j.oooo.2017.05.508 BP Vickery, JP Berglund, CM Burk, JP Fine, EH Kim, JI Kim, CA Keet, M Kulis, KG Orgel, R Guo, PH Steele, YV Virkud, P Ye, BL Wright, RA Wood, AW Burks. Early Oral Immunotherapy in Peanut‐allergic Preschool Children is Safe and Highly Effective. J Allergy Clin Immunol. 2017; doi: 10.1016/j.jaci.2016.05.027 A Hamad, EH Kim. Early Introduction of Allergenic Foods is Safe and May Be Beneficial. J Allergy Clin Immunol In Pract. 2016; doi: 10.1016/j.jaip.2016.09.042 C Burk, M Kulis, N Leung, EH Kim, AW Burks, BP Vickery. Utility of Component Analyses in Subjects Undergoing Sublingual Immunotherapy for Peanut Allergy. Clin Exp Allergy. 2016; doi: 10.1111/cea.12635 SJ Chin, BP Vickery, MD Kulis, EH Kim, P Varshney, P Steele, J Kamilaris, AM Hiegel, SK Carlisle, PB Smith, AM Scurlock, SM Jones, AW Burks. Sublingual Versus Oral Immunotherapy for Peanut‐allergic Children: A Retrospective Comparison. J Allergy Clin Immunol. 2013; doi: 10.1016/j.jaci.2013.02.017 MD Kulis, K Saba, EH Kim, JA Bird, N Kamilaris, BP Vickery, H Staats, AW Burks. Increased Peanut‐ specific IgA in Saliva Correlates with Food Challenge Outcomes Following Peanut Sublingual Immunotherapy. J Allergy Clin Immunol. 2012; doi: 10.1016/j.jaci.2011.11.045 EH Kim, JA Bird, MD Kulis, S Laubach, L Pons, WG Shreffler, PH Steele, J Kamilaris, BP Vickery, AW Burks. Sublingual Immunotherapy for Peanut Allergy: Clinical and Immunologic Evidence of Desensitization. J Allergy Clin Immunol. 2011; doi: 10.1016/j.jaci.2010.12.1083 TD Green, VS LaBelle, PH Steele, EH Kim, LA Lee, VS Mankad, LW Williams, KJ Anstrom, AW Burks. Clinical Characteristics of Peanut‐allergic Children: Recent Changes. Pediatrics. 2007; doi: 10.1542/peds.2007‐0350 N Danilova, VS Hohman, EH Kim, LA Steiner. Immunoglobulin Variable‐region Diversity in the Zebrafish. Immunogenetics. 2000; doi: 10.1007/s002510000255